TRGV1
Probable non-functional T cell receptor gamma variable
Also known as: TCRGV1, TRGV1_HUMAN, V1S1P
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A0A0A0MS02
- Gene
- TRGV1
- Ensembl
- ENSG00000211701
- Chromosome
- 7
- Canonical length
- 117 aa
- Protein class
- Predicted intracellular proteins, T-cell receptor genes
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to be involved in adaptive immune response. Predicted to be located in plasma membrane. Predicted to be part of T cell receptor complex. Predicted to be active in external side of plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
117 residues, UniProt reviewed canonical sequence.
>A0A0A0MS02|TRGV1
1 MRWALAVLLA FLSPASQISS NLEGRTKSVT RLTGSSAEIT CDLPGASTLY IHWYLHQEGK
61 APQCLLYYEP YYSRVVLESG ITPGKYDTGS TRSNWNLRLQ NLIKNDSGFY YCATWDRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRGV1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 1.4 nTPM
Expression across tissuesHPA
Tissue
- spleen: 1.4 nTPM
- lymph node: 1.3 nTPM
- appendix: 0.5 nTPM
- salivary gland: 0.5 nTPM
- duodenum: 0.4 nTPM
- bone marrow: 0.2 nTPM
Single-cell type
- adipocytes: 1.7 nCPM
- cardiomyocytes: 0.2 nCPM
- cdc: 0.2 nCPM
- macrophages: 0.2 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
Immune cell
- gdT-cell: 1.8 nTPM
- MAIT T-cell: 1.8 nTPM
- NK-cell: 1.7 nTPM
- memory CD8 T-cell: 1.2 nTPM
- memory CD4 T-cell: 0.8 nTPM
- naive CD8 T-cell: 0.8 nTPM
Brain region
- midbrain: 1.6 nTPM
- medulla oblongata: 1.5 nTPM
- white matter: 1.2 nTPM
- thalamus: 1 nTPM
- pons: 0.9 nTPM
- spinal cord: 0.8 nTPM
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRGV1 as an antibody target. Whether an autoantibody or antibody against TRGV1 could matter depends on whether native TRGV1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRGV1 is annotated at the cell surface, where native TRGV1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRGV1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...